#likelihood of confusion

The Madras High Court ruled that trademark passing off claims succeed when cumulative evidence demonstrates a real likelihood of consumer confusion, even in the absence of physical counterfeit products. This clarifies that brand protection hinges on market perception, not just imitation, empowering rights holders to act against deceptive trade practices without waiting for forged goods to surface.

Bombay HC rules that pharmaceutical trademarks require the 'lowest threshold of confusion' to protect public health, granting interim injunction against LIVOGEM for its deceptive similarity to LIVOGEN. The judgment reinforces strict scrutiny for marks in the pharmaceutical sector, where even minor confusion can pose significant risks.